Cargando…
Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is the most prevalent non-small cell lung cancer (NSCLC). Patients with LUAD have a poor 5-year survival rate. The use of immune checkpoint inhibitors (ICIs) for the treatment of LUAD has been on the rise in the past decade. This study explored the prognostic r...
Autores principales: | Ma, Weishuang, Liang, Jiaming, Mo, Junjian, Zhang, Siyuan, Hu, Ningdong, Tian, Dongbo, Chen, Zisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507344/ https://www.ncbi.nlm.nih.gov/pubmed/34635082 http://dx.doi.org/10.1186/s12885-021-08790-9 |
Ejemplares similares
-
Correction to: Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma
por: Ma, Weishuang, et al.
Publicado: (2021) -
Establishment and validation of an eight-gene metabolic–related prognostic signature model for lung adenocarcinoma
por: Ma, Weishuang, et al.
Publicado: (2021) -
Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma
por: Jiang, Zhongming, et al.
Publicado: (2019) -
Bibliometrics Analysis of Butyrophilins as Immune Regulators [1992–2019] and Implications for Cancer Prognosis
por: Wang, Yixi, et al.
Publicado: (2020) -
Butyrophilins: an important new element of resistance
por: Malinowska, Magdalena, et al.
Publicado: (2017)